Oct 26, 2022 / 11:00PM GMT
Unidentified Participant
Good afternoon. Next up, we have Dr. David Jin from Avalon GlobalCare.
David Jin - Avalon GloboCare Corp. - President & CEO
Good afternoon, everyone. My name is David Jin, the President and CEO of Avalon GloboCare. I really appreciate the opportunity to present in this LD Micro Conference today. I will be making some forward-looking statements, so please refer to our regulatory filings and the risk factors that are associated.
As a medical oncologist, I have a genuine passion in curing cancer. You are probably familiar with some of the conventional cancer treatment options as in the left.
Over the last decade, there is a revolutionary approach called cellular immunotherapy, mostly about something called CAR-T therapy, which involves the isolation and genetic engineering of T cells, which are the major workhorses in our body. And you can imagine these CAR-T cells as a living drug equipped with a GPS-guided missile, directly targeting tumor cells and killing them. And this is a very impressive and revolutionary approach
Avalon Globocare Corp at LD Micro Main Event Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot